Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation

Qingmin Kong,Botao Wang,Peijun Tian,Xiu Li,Jianxin Zhao,Hao Zhang,Wei Chen,Gang Wang
DOI: https://doi.org/10.1039/d0fo02375b
2021-01-01
Abstract:The present study aimed to assess the ability of three Lactobacillus strains ( L. helveticus CCFM1076, L. acidophilus La28, and L. acidophilus JCM 1132) to alleviate autistic-like behavioral symptoms in VPA-treated rats from weaning to sexual maturation.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the effects of three lactic acid bacteria (L. helveticus CCFM1076, L. acidophilus La28 and L. acidophilus JCM 1132) in alleviating autistic - like behavioral symptoms in young rats treated with sodium valproate (VPA) from weaning to sexual maturity. Specifically, the study aims to: 1. **Evaluate 5 - hydroxytryptamine (5 - HT) metabolic disorders**: For the first time, based on tryptophan metabolism, evaluate the synthesis of 5 - HT and its metabolic capacity in the peripheral nervous system (PNS) and the central nervous system (CNS). 2. **Analyze the gut microbiota and short - chain fatty acids (SCFAs)**: Evaluate the changes in the gut microbiota and SCFAs at the end of the 8th week. 3. **Explore the effects of lactic acid bacteria on the 5 - HT system**: In particular, the role of L. helveticus CCFM1076 in regulating 5 - HT synthesis and catabolism, balancing the release of excitatory and inhibitory neurotransmitters, and increasing the synthesis of hypothalamic oxytocin (OT). ### Research background Autism is a widespread neurodevelopmental disorder, often manifested as social communication disorders, impaired verbal and non - verbal communication, and repetitive behaviors. Studies have shown that abnormal 5 - HT signaling is one of the comorbidities of autism, and the 5 - HT system is closely related to other signaling systems (such as the oxytocin system) and jointly regulates emotional behavior. ### Research methods Researchers used a VPA - induced autistic rat model, and treated the experimental group rats with three lactic acid bacteria strains by gavage, and set up a control group and a healthy group for comparison. The main experimental steps include: 1. **Animal experiments**: Select Wistar rats, establish a VPA - induced autistic model, and conduct lactic acid bacteria intervention. 2. **Behavioral tests**: Including open - field test, marble - burying test, social test, novel object recognition test and forced swimming test, etc. 3. **Neuroendocrine secretion analysis**: Detect the levels of L - Trp, 5 - HTP, 5 - HT and 5 - HIAA in the colon, cerebellum, prefrontal cortex and serum. 4. **SCFA analysis**: Detect the content of short - chain fatty acids in feces. 5. **Gut microbiota analysis**: Extract fecal sample DNA, perform 16S rRNA sequencing and analyze microbial diversity. ### Main findings 1. **Lactic acid bacteria improve autistic - like behaviors**: In particular, L. helveticus CCFM1076 significantly improved social interaction, cognitive ability and repetitive stereotyped behaviors, and regulated depressive mood. 2. **Regulate 5 - HT system function**: L. helveticus CCFM1076 significantly up - regulated the levels of 5 - HT and its precursor substances L - Trp and 5 - HTP in the colon, feces and serum, and promoted the synthesis of 5 - HT metabolite 5 - HIAA. 3. **Balance excitatory and inhibitory neurotransmitters**: L. helveticus CCFM1076 significantly balanced the secretion of GABA and glutamate in the serum. 4. **Increase hypothalamic oxytocin synthesis**: L. helveticus CCFM1076 significantly increased the oxytocin synthesis in the hypothalamus of VPA - treated rats. 5. **Regulate gut microbiota**: L. helveticus CCFM1076 significantly reduced the relative abundance of Turicibacter and increased the butyrate level. ### Conclusion The results of this study indicate that L. helveticus CCFM1076 effectively alleviates the autistic - like behaviors of VPA - treated rats by regulating the synthesis and metabolism of the 5 - HT system, balancing the release of excitatory and inhibitory neurotransmitters, and increasing oxytocin synthesis. These findings provide new ideas for the development of biological products for the treatment of autism and a basis for further research on the impact of the gut environment on autism.